Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families

被引:41
作者
Grabowski, M
Muller-Koch, Y
Grasbon-Frodl, E
Koehler, U
Keller, G
Vogelsang, H
Dietmaier, W
Kopp, R
Siebers, U
Schmitt, W
Neitzel, B
Gruber, M
Doerner, C
Kerker, B
Ruemmele, P
Henke, G
Holinski-Feder, E
机构
[1] Ctr Med Genet, D-80336 Munich, Germany
[2] Univ Munich, Inst Human Genet, D-80336 Munich, Germany
[3] Univ Munich, Inst Neuropathol, D-81377 Munich, Germany
[4] Tech Univ Munich, Inst Pathol, D-81675 Munich, Germany
[5] Tech Univ Munich, Dept Surg, D-81675 Munich, Germany
[6] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany
[7] Univ Munich, Dept Surg, D-81377 Munich, Germany
[8] Univ Munster, Inst Human Genet, D-48149 Munster, Germany
[9] Krankenhaus Munchen Neuperlach, Dept Med, D-81737 Munich, Germany
来源
GENETIC TESTING | 2005年 / 9卷 / 02期
关键词
D O I
10.1089/gte.2005.9.138
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hereditary nonpolyposis colorectal cancer (HNPCC) is due to defects in DNA mismatch repair (MMR) genes MSH2, MLH1, MSH6, and to a lesser extent PMS2. Of 466 suspected HNPCC families, we defined 54 index patients with either tumors of high microsatellite instability (MSI-H) and/or loss of expression for either MLH1, MSH2, and/or MSH6, but without a detectable pathogenic point mutation in these genes. This study cohort was augmented to 64 patients by 10 mutation-negative index patients from Amsterdam families where no tumors were available. Deletion/duplication screening using the multiplex ligation-dependent probe amplification (MLPA) revealed 12 deletions in MSH2 and two deletions in MLH1. These deletions constitute 17% of pathogenic germline alterations but elucidate the susceptibility to HNPCC in only 22% of the mutation-negative study cohort, pointing towards other mutation mechanisms for an inherited inactivation of MLH1 or MSH2. We describe here four novel deletions. One novel and one known type of deletion were found for three and two unrelated families, respectively. MLPA analysis proved a reliable method for the detection of genomic deletions in MLH1 and MSH2; however, sequence variations in the ligation-probe binding site can mimic single exon deletions.
引用
收藏
页码:138 / 146
页数:9
相关论文
共 42 条
[1]  
Boland CR, 1998, CANCER RES, V58, P5248
[2]   Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium:: A population-based study in Northern Sweden [J].
Cederquist, K ;
Emanuelsson, M ;
Göransson, I ;
Holinski-Feder, E ;
Müller-Koch, Y ;
Golovleva, I ;
Grönberg, H .
INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (03) :370-376
[3]  
Charbonnier F, 2002, CANCER RES, V62, P848
[4]   Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing [J].
Christensen, M ;
Katballe, N ;
Wikman, F ;
Primdahl, H ;
Sorensen, FB ;
Laurberg, S ;
Orntoft, TF .
CANCER, 2002, 95 (11) :2422-2430
[5]  
de Leeuw WJF, 2000, J PATHOL, V192, P328, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH701>3.0.CO
[6]  
2-2
[7]   BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer [J].
Deng, GR ;
Bell, I ;
Crawley, S ;
Gum, J ;
Terdiman, JP ;
Allen, BA ;
Truta, B ;
Sleisenger, MH ;
Kim, YS .
CLINICAL CANCER RESEARCH, 2004, 10 (01) :191-195
[8]  
Dietmaier W, 1997, CANCER RES, V57, P4749
[9]   AGA technical review on hereditary colorectal cancer and genetic testing [J].
Giardiello, FM ;
Brensinger, JD ;
Petersen, GM .
GASTROENTEROLOGY, 2001, 121 (01) :198-213
[10]   Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach [J].
Gille, JJP ;
Hogervorst, FBL ;
Pals, G ;
Wijnen, JT ;
van Schooten, RJ ;
Dommering, CJ ;
Meijer, GA ;
Craanen, ME ;
Nederlof, PM ;
de Jong, D ;
McElgunn, CJ ;
Schouten, JP ;
Menko, FH .
BRITISH JOURNAL OF CANCER, 2002, 87 (08) :892-897